Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenias of Undetermined Significance: 2026 Update on Clinical Associations and Management Recommendations

Lung, Respiratory and Thoracic Cancer

Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024

Cancer

Florez N, Patel S, Wakelee HA, Rotow J, Shum E, Sands J, Salgia R, Hirsch FR, Peters S, Sabari J, Husain H, Bazhenova L, Massarelli E, Backhus LM, Lee P, Herbst RS, Bestvina C, Higgins K, Desai A, Dietrich M, Keshava HB, Halmos B, Gandara DR, Riess JW, Velázquez AI, Sibley A, Shields M, Sen T, Kim ES

doi: 10.1002/cncr.70060

Central Nervous System Tumors

Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study

J Clin Oncol

Berko ER, Naranjo A, Daniels AA, McNulty SN, Krytska K, Druley T, Zelley K, Koneru B, Chen L, Polkosnik G, Irwin MS, Bagatell R, Maris JM, Reynolds CP, DuBois SG, Park JR, Mossé YP

doi: 10.1200/JCO-24-02407

Lung, Respiratory and Thoracic Cancer

Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)

Lung Cancer

Borghetti P, D'Angelillo R, Facheris G, Borghesi A, Bruni A, Ceruti P, Ferrari K, Filippi AR, Ramella S, Signorelli D, Pappagallo G, Ricardi U, Collaborators

doi: 10.1016/j.lungcan.2025.108807

SPECIAL REPORT

Breast Cancer

Managing Side Effects in Breast Cancer Treatment

Further Publications

Clonal Hematopoiesis and Cardiovascular Disease Risk After Cancer Therapy in Patients With Solid Tumors

JAMA Oncol

Shyr D, Pershad Y, Zhao K, Kishtagari A, Corty RW, Shinohara E, Park BH, Heimlich JB, Luo L, Bick AG

doi: 10.1001/jamaoncol.2025.5785

Sarcoma

Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic retroperitoneal sarcoma working group (TARPSWG)

Cancer Treat Rev

Fabbroni C, Johnston EW, Sanfilippo R, Strauss DC, Bonvalot S, Spalek M, Van Houdt WJ, Ford SJ, Lee KW, Salawu A, Swallow CJ, Bae S, Gyorki DE, Raut CP, Mullinax JE, Albertsmeier M, Cananzi F, Konieczkowski D, Grignol VP, Pennacchioli E, Solli P, Napolitano A, Blasi ED, Wilkinson M, Stacchiotti S, Tzanis D, Rutkowski P, Bouhadiba T, Schrage YM, Sherriff J, Wang J, Callegaro D, Farma JM, Fiore M, Gervais MK, Gladdy RA, Nessim C, Roland CL, Cranmer L, Lee TY, Patel S, von Mehren M, Wagner AJ, Sicklick J, Gronchi A, Tseng WW

doi: 10.1016/j.ctrv.2025.103086

Further Publications

Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial

Lancet Haematol

Mahé I, Chapelle C, Girard P, Carrier M, Palomares LJ, Samama CM, Helfer H, Gerotziafas G, Laporte S, Vicaut E, Mismetti P, API-CAT Study Group, API-CAT Investigators

doi: 10.1016/S2352-3026(25)00291-1

Multiple Myeloma (MM)

Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma

J Clin Oncol

Aktas Samur A, Corre J, Talluri S, Shah P, Graffeuil A, Rivera J, Fan Y, Dakiki Korucu B, Szalat R, Fulciniti M, Anderson KC, Sperling A, Parmigiani G, Avet-Loiseau H, Munshi NC, Samur MK

doi: 10.1200/JCO-25-00289

Lung, Respiratory and Thoracic Cancer

Risk Factors Associated with Suboptimal Real-World Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Front-Line Recommended Therapy

Adv Ther

Spira AI, Ran T, Lin I, Chen C, He A, Belani N, Du S

doi: 10.1007/s12325-025-03234-3

Related content

Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024

Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study

Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)

Managing Side Effects in Breast Cancer Treatment

Clonal Hematopoiesis and Cardiovascular Disease Risk After Cancer Therapy in Patients With Solid Tumors

Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic retroperitoneal sarcoma working group (TARPSWG)

Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial

Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma

Risk Factors Associated with Suboptimal Real-World Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Front-Line Recommended Therapy